Literature DB >> 10550315

Stromal-cell derived factor is expressed by dendritic cells and endothelium in human skin.

J L Pablos1, A Amara, A Bouloc, B Santiago, A Caruz, M Galindo, T Delaunay, J L Virelizier, F Arenzana-Seisdedos.   

Abstract

Stromal-cell derived factor or SDF-1 is a CXC chemokine constitutively expressed by stromal bone marrow cell cultures that binds to the G-protein-coupled receptor CXCR4. SDF-1/CXCR4 represents a unique, nonpromiscuous ligand/receptor pair that plays an essential role in prenatal myelo- and lymphopoiesis as well as in cardiovascular and neural development. SDF-1 prevents entry of CXCR4-dependent (X4) HIV viruses in T lymphocytes, by binding and internalizing CXCR4. The expression pattern of SDF-1 protein in normal tissues is not known. Here we describe an analysis of SDF-1 mRNA and protein in normal and inflamed skin by in situ hybridization and immunohistochemistry, using a novel anti-SDF-1 monoclonal antibody. We also describe the expression pattern of CXCR4 receptor by immunohistochemistry. Our results show that SDF-1 protein and mRNA are normally expressed by endothelial cells, pericytes, and either resident or explanted CD1a+ dendritic cells. Epithelial cells of sweat glands but not keratinocytes also express SDF-1. In various inflammatory skin diseases, a large number of mononuclear cells and fibroblasts in close contact with CXCR4-positive lymphocytic infiltrates also express SDF-1. CXCR4 was also detected in many different normal cell types, including endothelial and epithelial cells, which points to a role for SDF-1/CXCR4 cell signaling in vascular and epithelial homeostasis. The demonstration of SDF-1 expression in dendritic and endothelial cells provides new insights into the mechanisms of normal and pathological lymphocyte circulation and makes it possible to envisage a role for locally secreted SDF-1 in the selective incapacity of mucosal dendritic cells to support and propagate infection by X4 HIV isolates.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10550315      PMCID: PMC1866989          DOI: 10.1016/S0002-9440(10)65474-0

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  41 in total

Review 1.  Dendritic cells and the control of immunity.

Authors:  J Banchereau; R M Steinman
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

2.  IL-4 induces functional cell-surface expression of CXCR4 on human T cells.

Authors:  P Jourdan; C Abbal; N Noraz; T Hori; T Uchiyama; J P Vendrell; J Bousquet; N Taylor; J Pène; H Yssel; N Nora
Journal:  J Immunol       Date:  1998-05-01       Impact factor: 5.422

3.  Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection.

Authors:  R S Veazey; M DeMaria; L V Chalifoux; D E Shvetz; D R Pauley; H L Knight; M Rosenzweig; R P Johnson; R C Desrosiers; A A Lackner
Journal:  Science       Date:  1998-04-17       Impact factor: 47.728

4.  Chemokines and the arrest of lymphocytes rolling under flow conditions.

Authors:  J J Campbell; J Hedrick; A Zlotnik; M A Siani; D A Thompson; E C Butcher
Journal:  Science       Date:  1998-01-16       Impact factor: 47.728

5.  Chemokine receptor CXCR4 expression in endothelium.

Authors:  M V Volin; L Joseph; M S Shockley; P F Davies
Journal:  Biochem Biophys Res Commun       Date:  1998-01-06       Impact factor: 3.575

6.  The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1.

Authors:  R Möhle; F Bautz; S Rafii; M A Moore; W Brugger; L Kanz
Journal:  Blood       Date:  1998-06-15       Impact factor: 22.113

7.  The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract.

Authors:  K Tachibana; S Hirota; H Iizasa; H Yoshida; K Kawabata; Y Kataoka; Y Kitamura; K Matsushima; N Yoshida; S Nishikawa; T Kishimoto; T Nagasawa
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

8.  Disturbed CD4+ T cell homeostasis and in vitro HIV-1 susceptibility in transgenic mice expressing T cell line-tropic HIV-1 receptors.

Authors:  S Sawada; K Gowrishankar; R Kitamura; M Suzuki; G Suzuki; S Tahara; A Koito
Journal:  J Exp Med       Date:  1998-05-04       Impact factor: 14.307

9.  Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes.

Authors:  F Sallusto; D Lenig; C R Mackay; A Lanzavecchia
Journal:  J Exp Med       Date:  1998-03-16       Impact factor: 14.307

10.  HIV-1 selection by epidermal dendritic cells during transmission across human skin.

Authors:  J C Reece; A J Handley; E J Anstee; W A Morrison; S M Crowe; P U Cameron
Journal:  J Exp Med       Date:  1998-05-18       Impact factor: 14.307

View more
  66 in total

1.  Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function.

Authors:  T Ponomaryov; A Peled; I Petit; R S Taichman; L Habler; J Sandbank; F Arenzana-Seisdedos; A Magerus; A Caruz; N Fujii; A Nagler; M Lahav; M Szyper-Kravitz; D Zipori; T Lapidot
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

2.  Langerhans cells renew in the skin throughout life under steady-state conditions.

Authors:  Miriam Merad; Markus G Manz; Holger Karsunky; Amy Wagers; Wendy Peters; Israel Charo; Irving L Weissman; Jason G Cyster; Edgar G Engleman
Journal:  Nat Immunol       Date:  2002-11-04       Impact factor: 25.606

Review 3.  CXCL12 in control of neuroinflammation.

Authors:  Miljana Momcilović; Marija Mostarica-Stojković; Djordje Miljković
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

4.  EphB2 and EphB4 receptors forward signaling promotes SDF-1-induced endothelial cell chemotaxis and branching remodeling.

Authors:  Ombretta Salvucci; Maria de la Luz Sierra; Jose A Martina; Peter J McCormick; Giovanna Tosato
Journal:  Blood       Date:  2006-07-13       Impact factor: 22.113

5.  Ectopic lymphoid neogenesis in psoriatic arthritis.

Authors:  Juan D Cañete; Begoña Santiago; Tineke Cantaert; Raimon Sanmartí; Antonio Palacin; Raquel Celis; Eduard Graell; Beatriz Gil-Torregrosa; Dominique Baeten; José L Pablos
Journal:  Ann Rheum Dis       Date:  2007-01-12       Impact factor: 19.103

6.  CXCL12-CXCR4 engagement is required for migration of cutaneous dendritic cells.

Authors:  Kenji Kabashima; Noriko Shiraishi; Kazunari Sugita; Tomoko Mori; Ayako Onoue; Miwa Kobayashi; Jun-Ichi Sakabe; Ryutaro Yoshiki; Hirokazu Tamamura; Nobutaka Fujii; Kayo Inaba; Yoshiki Tokura
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

7.  Lymphotoxin-alpha 1 beta 2 and LIGHT induce classical and noncanonical NF-kappa B-dependent proinflammatory gene expression in vascular endothelial cells.

Authors:  Lisa A Madge; Martin S Kluger; Jordan S Orange; Michael J May
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

8.  Influence of ERK activation on decreased chemotaxis of mature human cord blood monocyte-derived dendritic cells to CCL19 and CXCL12.

Authors:  Geling Li; Sunanda Basu; Myung-Kwan Han; Young-June Kim; Hal E Broxmeyer
Journal:  Blood       Date:  2006-12-19       Impact factor: 22.113

9.  Homeostatic and tissue reparation defaults in mice carrying selective genetic invalidation of CXCL12/proteoglycan interactions.

Authors:  Patricia Rueda; Adèle Richart; Alice Récalde; Pamela Gasse; José Vilar; Coralie Guérin; Hugues Lortat-Jacob; Paulo Vieira; Franoise Baleux; Fabrice Chretien; Fernando Arenzana-Seisdedos; Jean-Sébastien Silvestre
Journal:  Circulation       Date:  2012-10-03       Impact factor: 29.690

Review 10.  Warts and all: human papillomavirus in primary immunodeficiencies.

Authors:  Jennifer W Leiding; Steven M Holland
Journal:  J Allergy Clin Immunol       Date:  2012-10-01       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.